Skip to main content
Erschienen in: Herz 5/2023

11.01.2023 | Review articles

Comparison of outcomes between single long stent and overlapping stents: a meta-analysis of the literature

verfasst von: Faysal Şaylık, M.D., Tufan Çınar, M.D., Murat Selçuk, M.D., Vedat Çiçek, M.D., Mert Ilker Hayıroğlu, M.D., Ahmet Lütfullah Orhan, M.D.

Erschienen in: Herz | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Objectives

There is no consensus on whether to treat diffuse coronary artery lesions with a single long stent (SLS) or by overlapping two or more stents (OLS). The goal of this review was to compare the outcomes of these two approaches through a meta-analysis of the literature.

Methods

We searched for relevant studies in MEDLINE, Scopus, EMBASE, Google Scholar, and the Cochrane Library. Our meta-analysis included 12 studies (n = 6414) that reported outcomes during the follow-up period.

Results

Individuals who received OLS had a greater risk of cardiac mortality and target lesion revascularization (TLR) than those who received SLS (RR: 1.51, CI: 1.03–2.21, p = 0.03, I2 = 0% and RR: 1.64, CI: 1.02–2.65, p = 0.04, I2 = 38%, respectively). The fluoroscopy period in the OLS group was longer than in the SLS group (SMD: 0.35, CI: 0.25–0.46, p < 0.01, I2 = 0%). more contrast volume was sued for the OLS group; however, there was substantial variability in the pooled analysis (I2 = 95%). In terms of all outcomes, there were no differences between stent generation types.

Conclusion

In the first meta-analysis of mainly observational data comparing OLS vs. SLS for long coronary lesions, OLS had higher rates of cardiac mortality and TLR as well as longer fluoroscopy times compared to SLS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Caputo RP et al (2012) Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry). Am J Cardiol 110:350–355CrossRefPubMed Caputo RP et al (2012) Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry). Am J Cardiol 110:350–355CrossRefPubMed
2.
Zurück zum Zitat Negreira-Caamaño M et al (2021) Percutaneous intervention in diffuse coronary disease: overlapping versus single very long stent technique. Results from the OVERLONG registry. Angiology 72:979–985CrossRefPubMed Negreira-Caamaño M et al (2021) Percutaneous intervention in diffuse coronary disease: overlapping versus single very long stent technique. Results from the OVERLONG registry. Angiology 72:979–985CrossRefPubMed
3.
Zurück zum Zitat Jurado-Román A et al (2019) Comparison of clinical outcomes between very long stents and overlapping stents for the treatment of diffuse coronary disease in real clinical practice. Cardiovasc Revasc Med 20:681–686CrossRefPubMed Jurado-Román A et al (2019) Comparison of clinical outcomes between very long stents and overlapping stents for the treatment of diffuse coronary disease in real clinical practice. Cardiovasc Revasc Med 20:681–686CrossRefPubMed
4.
Zurück zum Zitat Ortega-Paz L et al (2017) Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial. EuroIntervention 13:e557–e563CrossRefPubMed Ortega-Paz L et al (2017) Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial. EuroIntervention 13:e557–e563CrossRefPubMed
5.
Zurück zum Zitat Räber L et al (2010) Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. J Am Coll Cardiol 55:1178–1188CrossRefPubMed Räber L et al (2010) Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. J Am Coll Cardiol 55:1178–1188CrossRefPubMed
6.
Zurück zum Zitat Aoki J et al (2005) “Full metal jacket” (stented length ≥64 mm) using drug-eluting stents for de novo coronary artery lesions. Am Heart J 150:994–999CrossRefPubMed Aoki J et al (2005) “Full metal jacket” (stented length ≥64 mm) using drug-eluting stents for de novo coronary artery lesions. Am Heart J 150:994–999CrossRefPubMed
7.
Zurück zum Zitat Balakrishnan B et al (2005) Strut position, blood flow, and drug deposition. Circulation 111:2958–2965CrossRefPubMed Balakrishnan B et al (2005) Strut position, blood flow, and drug deposition. Circulation 111:2958–2965CrossRefPubMed
8.
Zurück zum Zitat Valero E et al (2018) Initial experience with the novel BioMime 60 mm-long sirolimus-eluting tapered stent system in long coronary lesions. EuroIntervention 13:1591–1594CrossRefPubMed Valero E et al (2018) Initial experience with the novel BioMime 60 mm-long sirolimus-eluting tapered stent system in long coronary lesions. EuroIntervention 13:1591–1594CrossRefPubMed
9.
Zurück zum Zitat Lee SH et al (2004) Overlapping vs. one long stenting in long coronary lesions. Catheter Cardiovasc Interv 62:298–302CrossRefPubMed Lee SH et al (2004) Overlapping vs. one long stenting in long coronary lesions. Catheter Cardiovasc Interv 62:298–302CrossRefPubMed
10.
Zurück zum Zitat Sim HW et al (2020) Treating very long coronary artery lesions in the contemporary drug-eluting-stent era: single long 48 mm stent versus two overlapping stents showed comparable clinical outcomes. Cardiovasc Revasc Med 21:1115–1118CrossRefPubMed Sim HW et al (2020) Treating very long coronary artery lesions in the contemporary drug-eluting-stent era: single long 48 mm stent versus two overlapping stents showed comparable clinical outcomes. Cardiovasc Revasc Med 21:1115–1118CrossRefPubMed
11.
Zurück zum Zitat Amirzadegan A, et al (2019) Single long stents versus overlapping multiple stents in the management of very long coronary lesions: comparisons of procedures and clinical outcomes. J Tehran Heart Cent 14:94–102PubMedPubMedCentral Amirzadegan A, et al (2019) Single long stents versus overlapping multiple stents in the management of very long coronary lesions: comparisons of procedures and clinical outcomes. J Tehran Heart Cent 14:94–102PubMedPubMedCentral
12.
Zurück zum Zitat Hoffmann R et al (2002) Randomized comparison of success and adverse event rates and cost effectiveness of one long versus two short stents for treatment of long coronary narrowings. Am J Cardiol 90:460–464CrossRefPubMed Hoffmann R et al (2002) Randomized comparison of success and adverse event rates and cost effectiveness of one long versus two short stents for treatment of long coronary narrowings. Am J Cardiol 90:460–464CrossRefPubMed
13.
Zurück zum Zitat Abellán-Huerta J et al (2019) TCT-296 comparison between the use of very long stents and overlapping stents for the treatment of diffuse coronary artery disease: a real-life registry. J Am Coll Cardiol 74:B294CrossRef Abellán-Huerta J et al (2019) TCT-296 comparison between the use of very long stents and overlapping stents for the treatment of diffuse coronary artery disease: a real-life registry. J Am Coll Cardiol 74:B294CrossRef
14.
Zurück zum Zitat Buszman P et al (2017) TCT-748 long term outcome after revascularization of long coronary artery lesions with very long or overlapping stents. Insights from the propensity score matched registry. J Am Coll Cardiol 70:B317CrossRef Buszman P et al (2017) TCT-748 long term outcome after revascularization of long coronary artery lesions with very long or overlapping stents. Insights from the propensity score matched registry. J Am Coll Cardiol 70:B317CrossRef
15.
Zurück zum Zitat Balachandran A et al (2014) Clinical profile and outcomes of overlapping v/s single long stent in long coronary lesions—the Trivandrum long stent (TRILO) study. Indian Heart J 66:102–103CrossRef Balachandran A et al (2014) Clinical profile and outcomes of overlapping v/s single long stent in long coronary lesions—the Trivandrum long stent (TRILO) study. Indian Heart J 66:102–103CrossRef
16.
Zurück zum Zitat Park JY et al (2011) AS-218 cost-effectiveness of single 38 mm Paclitaxel-eluting stent for diffuse long lesion compared with two or more overlapping Sirolimus-eluting stents in Asian population. Am J Cardiol 107:81A–82ACrossRef Park JY et al (2011) AS-218 cost-effectiveness of single 38 mm Paclitaxel-eluting stent for diffuse long lesion compared with two or more overlapping Sirolimus-eluting stents in Asian population. Am J Cardiol 107:81A–82ACrossRef
17.
Zurück zum Zitat Fei G et al (2010) e0499 long term clinical follow-up of patients with versus without overlapping drug eluting stents for long coronary lesions. Heart 96:A155CrossRef Fei G et al (2010) e0499 long term clinical follow-up of patients with versus without overlapping drug eluting stents for long coronary lesions. Heart 96:A155CrossRef
18.
Zurück zum Zitat Won KH et al (2020) Comparison of efficacy of overlapped versus long eluting stent in acute myocardial infarction patients with diffuse long lesion. J Korean Soc Radiol 14:319–336 Won KH et al (2020) Comparison of efficacy of overlapped versus long eluting stent in acute myocardial infarction patients with diffuse long lesion. J Korean Soc Radiol 14:319–336
19.
Zurück zum Zitat Sianos G et al (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219–227PubMed Sianos G et al (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219–227PubMed
20.
Zurück zum Zitat Rikhtegar F et al (2014) Hemodynamics in coronary arteries with overlapping stents. J Biomech 47:505–511CrossRefPubMed Rikhtegar F et al (2014) Hemodynamics in coronary arteries with overlapping stents. J Biomech 47:505–511CrossRefPubMed
21.
Zurück zum Zitat Kitabata H et al (2013) Safety and efficacy outcomes of overlapping second-generation Everolimus-eluting stents versus first-generation drug-eluting stents. Am J Cardiol 112:1093–1098CrossRefPubMed Kitabata H et al (2013) Safety and efficacy outcomes of overlapping second-generation Everolimus-eluting stents versus first-generation drug-eluting stents. Am J Cardiol 112:1093–1098CrossRefPubMed
22.
Zurück zum Zitat O’Sullivan CJ et al (2014) Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents. EuroIntervention 9:1076–1084CrossRefPubMed O’Sullivan CJ et al (2014) Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents. EuroIntervention 9:1076–1084CrossRefPubMed
23.
Zurück zum Zitat Farooq V et al (2013) Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program. Heart 99:626CrossRefPubMed Farooq V et al (2013) Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program. Heart 99:626CrossRefPubMed
Metadaten
Titel
Comparison of outcomes between single long stent and overlapping stents: a meta-analysis of the literature
verfasst von
Faysal Şaylık, M.D.
Tufan Çınar, M.D.
Murat Selçuk, M.D.
Vedat Çiçek, M.D.
Mert Ilker Hayıroğlu, M.D.
Ahmet Lütfullah Orhan, M.D.
Publikationsdatum
11.01.2023
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 5/2023
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-022-05152-4

Weitere Artikel der Ausgabe 5/2023

Herz 5/2023 Zur Ausgabe

TAVI bei kleinem Aortenklappenanulus: Es gibt noch ungeklärte Fragen

13.06.2024 TAVI Nachrichten

Zwischen selbstexpandierenden und ballonexpandierbaren TAVI-Klappen scheinen bezüglich der Klappenfunktion bei Aortenstenose und kleinem Aortenklappenanulus Unterschiede zu bestehen. Aber sind die überhaupt von klinischer Relevanz? Eine neue Studie liefert dazu Informationen.

Degenerierte Bioklappe: Ist Reoperation oder TAVI hier die bessere Option?

13.06.2024 TAVI Nachrichten

Im Fall eines Bioprothesen-Versagens nach Aortenklappenersatz kann ein notwendiger Revisionseingriff heute operativ oder kathetergestützt als Valve-in-Valve-TAVI vorgenommen werden. Eine Beobachtungsstudie lieferte neue Daten zum Vergleich beider Optionen.

Exazerbationen der COPD bedrohen auch das Herz

12.06.2024 COPD-Exazerbation Nachrichten

Kardiovaskuläre Erkrankungen sind die häufigsten Komorbiditäten von Patienten mit COPD. Exazerbationen der Lungenkrankheit bedrohen Herz und Gefäße aber auch ohne bereits bestehendes Begleitleiden, wie eine Studie zeigt.

Vorhofflimmern: Adipöse Patienten profitieren von dualer Kardioversion

11.06.2024 Vorhofflimmern Nachrichten

Bei stark übergewichtigen Personen lässt sich Vorhofflimmern mit zwei gleichzeitigen Schocks und einer insgesamt höheren Schockenergie effektiver stoppen als mit der herkömmlichen Single-Kardioversion, und das ohne höheres Komplikationsrisiko.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.